Flentje D, Feichter G, Flentje M, Krämer K L, Goerttler K, Schlag P
J Cancer Res Clin Oncol. 1987;113(1):87-90. doi: 10.1007/BF00389972.
In vitro colony formation and chemosensitivity were analyzed in 65 human solid tumors and compared to proliferation parameters simultaneously obtained by DNA flow cytometry of the same tumor specimens. Colony growth in the human tumor colony assay was enhanced in aneuploid tumors (39/65) in comparison to diploid tumors (26/65, P less than 0.05). In addition, there was a relationship between % S-phase and colony growth. The existence of polyploid sublines (23/65) improved in vitro growth even in tumors with a diploid main G0/1-peak or with a low % S-phase. Metastases exhibited a higher proportion of aneuploidy and showed slightly better growth in vitro than primary tumors. Sensitivity testing in 34 of the 65 tumors showed no convincing relation between DNA parameters and the inhibition of colony formation by five standard anticancer agents with different mechanisms of action. This indicates additional factors other than the proliferative activity of the tumor to be responsible for drug sensitivity or resistance.
对65例人类实体瘤进行了体外集落形成和化学敏感性分析,并与通过对相同肿瘤标本进行DNA流式细胞术同时获得的增殖参数进行比较。与二倍体肿瘤(26/65)相比,非整倍体肿瘤(39/65)在人类肿瘤集落试验中的集落生长增强(P<0.05)。此外,S期百分比与集落生长之间存在关系。即使在具有二倍体主要G0/1峰或S期百分比低的肿瘤中,多倍体亚系(23/65)的存在也改善了体外生长。转移灶显示出更高比例的非整倍体,并且在体外生长略优于原发性肿瘤。65例肿瘤中的34例进行的敏感性测试表明,DNA参数与五种具有不同作用机制的标准抗癌药物对集落形成的抑制之间没有令人信服的关系。这表明除肿瘤增殖活性外,还有其他因素导致药物敏感性或耐药性。